To view the PDF file, sign up for a MySharenet subscription.

NDALA INVESTMENTS NO.1 (RF) LIMITED - NDAL11 - Approval of the holders of Series Transaction 9, Class A Notes in relation to amendments of the Applicable Pricing Supplement

Release Date: 20/10/2026 14:37
Code(s): NDAL11     PDF:  
Wrap Text
NDAL11 - Approval of the holders of Series Transaction 9, Class A Notes in relation to amendments of the Applicable Pricing Supplement 

Ndala Investments No. 1 (RF) Limited
Registration Number: 2008/029037/06
JSE Alpha code: NDAI


REQUEST FOR THE APPROVAL OF THE HOLDERS OF SERIES TRANSACTION 9, CLASS A NOTES IN
RELATION TO AMENDMENTS OF THE APPLICABLE PRICING SUPPLEMENT


1.     We refer to the programme memorandum dated on or about 17 April 2019 establishing the Ndala
       Investments No. 1 (RF) Limited secured note programme (the "Issuer Programme"), as
       supplemented by (i) the applicable transaction supplement dated on or about 17 February 2025
       (the "Applicable Transaction Supplement") relating to series transaction 9 under the Issuer
       Programme ("Series Transaction 9"), and (ii) the applicable pricing supplement dated on or about
       21 February 2025 relating to the Class A Notes issued under Series Transaction 9 (the "Series
       Transaction 9, Class A Applicable Pricing Supplement").


2.     Capitalised terms used but not defined herein shall bear the meaning ascribed thereto in the Applicable
       Transaction Supplement.


3.     The South African Reserve Bank has announced that the Johannesburg Interbank Average Rate
       ("JIBAR") will cease to be published after 31 December 2026. The South African Rand Overnight
       Index Average ("ZARONIA") has been developed as a replacement benchmark rate. It is proposed
       that the reference rate of the Class A Notes issued under Series Transaction 9 ("Series
       Transaction 9, Class A Notes"), as well as the reference rate of the Loans advanced under the Loan
       Facilities Agreement, be changed from JIBAR to compounded daily ZARONIA.


4.     Accordingly, this request for approval is delivered to each holder of the Series Transaction 9, Class A
       Notes (“Series Transaction 9, Class A Noteholders”), in order to obtain their approval, in accordance
       with Conditions 19.2 and 24.1.3, in respect of the proposed amendment of:


       4.1.    the Series Transaction 9, Class A Applicable Pricing Supplement, on the basis set out in the
               draft restated and amended Series Transaction 9, Class A Applicable Pricing Supplement, for
               the purpose of changing the reference rate of the Series Transaction 9, Class A Notes from
               JIBAR to compounded daily ZARONIA; and


       4.2.    the Loan Facilities Agreement, for the purpose of changing the reference rate of the Loans
               from JIBAR to compounded daily ZARONIA,


       (collectively, the "Proposed Amendments").
5.     A copy of the Series Transaction 9, Class A Applicable Pricing Supplement, marked-up to reflect the
       Proposed Amendments, is available on the Issuer’s website (Debt Investors | Nedbank).


6.     We hereby request that you approve the Proposed Amendments by completing and signing the
       extraordinary written resolution attached hereto as Annexure A and delivering same to the relevant
       CSD Participant and to Nedbank Corporate and Investment Banking, a division of Nedbank Limited
       by no later than 17 November 2026 in accordance with the terms of the extraordinary written
       resolution.


7.     We confirm that, to the extent required in terms of the Series Transaction Documents, the relevant
       Proposed Amendments have been approved in writing by the Series Security SPV.


20 October 2026


Debt Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited

                                                        ANNEXURE A


                                     NDALA INVESTMENTS NO. 1 (RF) LIMITED

 (Incorporated on 11 December 2008 with limited liability in the Republic of South Africa under Registration Number 2008/029037/06)

                             NDALA MULTI-ISSUER SECURED NOTE PROGRAMME

                                                 SERIES TRANSACTION 9



     WRITTEN RESOLUTION OF THE HOLDERS OF THE CLASS A NOTES IN SERIES TRANSACTION 9




BACKGROUND


Under the Ndala Investments No. 1 (RF) Limited Secured Note Programme (the "Issuer Programme"), Ndala
Investments No. 1 (RF) Limited (the "Issuer") issued limited recourse secured floating rate notes pursuant to
the programme memorandum dated on or about 17 April 2019, as supplemented by the applicable transaction
supplement dated on or about 17 February 2025 (the "Applicable Transaction Supplement") relating to
series transaction 9 under the Issuer Programme ("Series Transaction 9").


Capitalised terms used but not defined herein shall bear the meaning ascribed thereto in the Applicable
Transaction Supplement.


RECORDAL


We refer to the written notice to the holders of the Class A Notes issued under Series Transaction 9 ("Series
Transaction 9, Class A Noteholders") dated on or about 20 October 2026 (the "Approval Request").


We, __________________________________________________________________________________ ,
being a Series Transaction 9, Class A Noteholder (or a duly authorised representative of the Series
Transaction 9, Class A Noteholder) hereby confirm that we currently hold Class A Notes issued under Series
Transaction 9.


We acknowledge receipt of the Approval Request, requesting the Series Transaction 9, Class A Noteholders
to approve the amendment of:


1.       the applicable pricing supplement dated on or about 21 February 2025 relating to the Class A Notes
         issued under Series Transaction 9 ("Series Transaction 9, Class A Applicable Pricing
         Supplement"), on the basis set out in the draft restated and amended Series Transaction 9, Class A
         Applicable Pricing Supplement ("Restated and Amended Applicable Pricing Supplement"), for the
         purpose of changing the reference rate of the Series Transaction 9, Class A Notes from JIBAR to
         compounded daily ZARONIA; and
2.      the Loan Facilities Agreement, for the purpose of changing the reference rate of the Loans from JIBAR
        to compounded daily ZARONIA.


A copy of the Series Transaction 9, Class A Applicable Pricing Supplement, marked-up to reflect the Proposed
Amendments, is available on the Issuer’s website (Debt Investors | Nedbank).

GENERAL

The Series Transaction 9, Class A Noteholders must, by no later than 17 November 2026:


1.      submit a copy of the completed written extraordinary resolution with the CSD Participant which
        provided them with the Approval Request and the written extraordinary resolution; and


2.      email a copy of the completed written extraordinary resolution to Nedbank Corporate and Investment
        Banking, a division of Nedbank Limited at [Hendrika@Nedbank.co.za].


WRITTEN RESOLUTION


It is resolved that the amendment of (i) the Series Transaction 9, Class A Applicable Pricing Supplement, on
the basis as set out in the Restated and Amended Applicable Pricing Supplement; and (ii) the Loan Facilities
Agreement, for the purpose of changing the reference rate of the Loans from JIBAR to compounded daily
ZARONIA, be and is hereby:

 Bond Code      Written         Debt securities   Debt securities   Votes carried     Votes against    Votes
                Extraordinary   voted as a        voted             for         the   the resolution   abstained as a
                Resolution      Rand value        disclosed as a    resolution as a   as           a   percentage
                                                  percentage        percentage        percentage


 NDAL11         1




 Signed by: _________________________                     Signature _________________________



                                                          Date _________________________ 2026
Date: 20/10/2026 02:37:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.